For older adults, the flu vaccine could look a little different this year. Last week, the US Food and Drug Administration ...

Moderna’s newly approved vaccine could allow manufacturers to respond more rapidly to changing influenza strains.

Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing ...

After several disastrous flu seasons, there is some good news: The U.S. Food and Drug Administration approved a new, more ...

The Food and Drug Administration just approved the new type of flu vaccine for adults ages 50 and older. It relies on the ...

FLUSIVA is now the first and only mRNA standalone seasonal influenza vaccine on the market, marking a major advancement for ...

Stocks of crude oil in the U.S. Strategic Petroleum Reserve fell by about 6.1 million barrels to 298.7 million barrels last week, the lowest level since January 1983, according to data from the ...

The FDA tried to block it. Now the first mRNA flu shot is approved—here is who is eligible, and who is not.

Moderna’s mFLUSIVA is the first mRNA vaccine approved for seasonal flu. Its route to approval was unusual, with the FDA initially rejecting the application before reversing course.

Millions of older Americans will have access to a new type of influenza vaccine after the Food and Drug Administration ...